Patient Engagement in Asthma Treatment Plans May Improve Quality of Life

Share this content:
Patient Engagement in Asthma Treatment Plans May Improve Quality of Life
Patient Engagement in Asthma Treatment Plans May Improve Quality of Life

MONDAY, July 2, 2018 (HealthDay News) -- Older adults with asthma and a greater desire for involvement in decision making have higher asthma-related quality of life, according to a study published in the July issue of the Annals of Allergy, Asthma & Immunology.

Keerthi R. Karamched, M.D., from the University of Michigan in Ann Arbor, and colleagues sought to identify factors associated with autonomy and to determine whether autonomy is related to outcomes among 189 adults >55 years with persistent asthma. Preferences for autonomy were assessed using the Autonomy Preference Index. Scores were separated into the domains of information seeking and decision making preferences.

The researchers found that higher decision making preference scores were related to female gender, higher education level, and lower depression scores. Decision making scores were also positively correlated with asthma quality of life questionnaire scores. However, there was no association between decision making scores and asthma control test scores, spirometry values, or health care utilization. In addition, there was an association between information seeking preference scores and education level but not asthma outcomes.

"Future studies with the intention to increase patient autonomy may help establish a causal relationship," write the authors.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »